Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

1.170 -0.490 (-29.52%)
Streaming Delayed Price Updated: 1:28 PM EDT, Jul 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nautilus Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Top stock movements in today's session. ↗
Via Chartmill
Which stocks are gapping on Tuesday? ↗
Via Chartmill
News headline image
Nautilus Biotechnology Q2 Earnings Call Highlights ↗
Nautilus Biotechnology (NASDAQ:NAUT) said it is shifting a significant share of its research and development resources toward proteoform applications, citing customer interest and a delay in its... 
Via MarketBeat
Topics Earnings
News headline image
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Inc (NASDAQ:NAUT) Reports Narrower Q4 Loss, Maintains 2027 Cash Runway ↗
Via Chartmill
News headline image
Earnings Scheduled For October 28, 2025 ↗
 
Via Benzinga
News headline image
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus (NAUT) Q1 2026 Earnings Transcript ↗
Nautilus (NAUT) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard ↗
The real brain computer interface opportunity isn’t in the headlines. These 10 stocks are building the systems that make it possible. 
Via InvestorPlace
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Q1 Virtual Investor Summit Presentations Now Available On Demand
Via ACCESS Newswire
News headline image
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
Via ACCESS Newswire
News headline image
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform 
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus (NAUT) Q4 2025 Earnings Call Transcript ↗
Nautilus (NAUT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
Early Access Program participants receive exclusive use of Nautilus’ Iterative Mapping method, initially through a validated tau proteoforms assay, with the potential to accelerate Alzheimer’s and... 
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Which stocks are moving on Monday? ↗
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus (NAUT) Q3 2025 Earnings Call Transcript ↗
Nautilus (NAUT) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
What's going on in today's session ↗
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.